54 results on '"Meyers, Gabrielle"'
Search Results
2. Assessment of Mobility Trajectories Using Wearable Inertial Sensors During Autologous Hematopoietic Cell Transplant
3. Frailty and Preoperative Palliative Care in Surgical Oncology
4. Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques
5. Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia
6. Day 4 collection of granulocyte colony-stimulating factor-mobilized HLA-matched sibling donor peripheral blood allografts demonstrates no long-term increase in chronic graft-versus-host disease or relapse rates
7. A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease
8. Feasibility and cost analysis of day 4 granulocyte colony-stimulating factor mobilized peripheral blood progenitor cell collection from HLA-matched sibling donors
9. Outcomes of Autologous Hematopoietic Cell Transplantation in Older Patients with Diffuse Large B-Cell Lymphoma
10. Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse
11. Circulating Angiogenic Factors Associated with Response and Survival in Patients with Acute Graft-versus-Host Disease: Results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802
12. Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Phase 1 Trial
13. Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of Patients with Hematologic Malignancies Using Busulfan, Fludarabine, and Total Body Irradiation Conditioning Is Effective in an Elderly and Infirm Population
14. Induction Bortezomib in AL Amyloidosis Followed By High Dose Melphalan and Autologous Stem Cell Transplantation: A Single Institution Retrospective Study
15. Access to Allogeneic Hematopoietic Cell Transplant for Patients with Hematologic Malignancies in Oregon
16. The Impact of Telehealth Visits on Access to Transplant Care for Recipients of Allogeneic Hematopoietic Cell Transplantation in the State of Oregon
17. Impact of ABO Compatibility on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT): Ptcy Impacts Platelet Engraftment, Independent of ABO Compatibility
18. Control of an Outbreak of Human Parainfluenza Virus 3 in Hematopoietic Stem Cell Transplant Recipients
19. 171 - Allogeneic Stem Cell Transplantation in Treatment Related and Secondary Acute Myeloid Leukemia and Myelodysplastic Syndrome: Ohsu Experience
20. Myelodysplasia and Acute Leukemia as Late Complications of Marrow Failure: Future Prospects for Leukemia Prevention
21. The Management of Paroxysmal Nocturnal Hemoglobinuria: Recent Advances in Diagnosis and Treatment and New Hope for Patients
22. Prognostic Significance of NCAM1 (CD56) Expression in AML Patients Treated with HMA+Venetoclax
23. Acute Myeloid Leukemia Differentiation State and Genotype Influence Anti-Apoptotic Protein Expression, Venetoclax Sensitivity, and Survival in AML
24. MDS-009 Enhanced Survival of Chronic Myelomonocytic Leukemia (CMML)-Dysplastic Over the Proliferative Subtype After Allogeneic Hematopoietic Cell Transplantation: A Tertiary Center Experience
25. POSTER: MDS-009 Enhanced Survival of Chronic Myelomonocytic Leukemia (CMML)-Dysplastic Over the Proliferative Subtype After Allogeneic Hematopoietic Cell Transplantation: A Tertiary Center Experience
26. Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH)
27. 156 - Overall Survival in Myelofibrosis Treated with Allogeneic Hematopoietic Cell Transplant Is Impacted By Reversal of Marrow Fibrosis: A Single Institution Experience from Oregon Health and Science University
28. 450 - Bacterial Infections Post-Allogeneic Transplant Are Associated with Higher Relapse Related Mortality
29. Success and Satisfaction with Virtual Hematology Curriculum Implemented in Response to COVID-19
30. FLT3-Mutated Acute Myeloid Leukemia Using a Novel Regimen of Gemtuzumab Ozogamicin and Midostaurin in Combination with Standard Cytarabine and Daunorubicin Induction Therapy
31. Early Infection after Allogeneic Transplant Increases NRM without Influencing Relapse Rate
32. Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizumab, in Subjects with Newly Diagnosed Acute Graft Versus Host Disease
33. Retrospect Reviews of PNH Tests with Long-Term Follow-up in a Single Institution
34. Feasibility and Cost Analysis of Day 4 Granulocyte Colony-Stimulating Factor Mobilized Peripheral Blood Progenitor Cell Collection from HLA-Matched Sibling Donors
35. Feasibility and Cost Analysis of Day 4 Granulocyte Colony-Stimulating Factor Mobilized Peripheral Blood Progenitor Cell Collection from HLA-Matched Sibling Donors
36. 359 - Utilization of Palliative Care Services PRIOR to Death in Patients Following Hematopoietic STEM CELL Transplant
37. Healthcare Consumption Amongst Older Patients with High Risk AML Treated with Hypomethylating Agents Is Similar to That of Patients Receiving Induction Chemotherapy
38. Identifying Unexpected Inherited Marrow Failure Syndromes in Adults Presenting with Aplastic Anemia, MDS or Solid Tumors
39. Transplant Program Enhancement: Application of Lean Processes to HSCT Program Improvement Efforts
40. Feasibility of Day 4 G-CSF mobilized peripheral blood stem collection from HLA-matched sibling donors
41. Feasibility of Day 4 G-CSF Mobilized Peripheral Blood Stem Collection from HLA-Matched Sibling Donors
42. Placental Growth Factor (PlGF) in Allogeneic Hematopoietic Cell Transplantation (HCT): Clinical, Immunologic, and Pathologic Correlates
43. Prognostic Impact of Follistatin in Acute Graft-Versus-Host Disease: Results from BMT CTN 0302 and 0802
44. Elevated Placental Growth Factor Levels after Allogeneic Hematopoietic Cell Transplantation: Clinical and Peripheral Blood Mononuclear Cell Receptor Expression Correlates
45. The Contribution of Toll-like Receptor (TLR) Pathway Hyper-Reactivity to Clonal Selection in Secondary MDS and AML
46. Circulating Angiogenic Factors As Biomarkers of Acute Gvhd Onset and Response to Therapy: Repair and Regeneration Versus Endothelial Damage and Inflammation
47. Chronic GVHD-Associated Serositis and Pericarditis
48. Predictive Classification of Chronic GVHD Status by Immune Reconstitution Testing
49. Applying the Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) in Myeloablative MUD Transplants Predicts NRM and OS Using a Modified 2-Tier Scoring System.
50. Disease-Related Symptoms Reported across a Broad Population of Patients with Paroxysmal Nocturnal Hemoglobinuria.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.